We recently compiled a list of 10 Best Stocks To Buy Right Now According To Billionaire Cliff Asness. In this article, we ...

Today, Benzinga's options scanner identified 12 options transactions for McKesson. This is an unusual occurrence. The ...

Two drug distribution companies at one point controlled 60% of the prescription opioid market in the Baltimore area, sending ...

McKesson declined about 20% in the last few weeks and sentiment suddenly turned. Of course, McKesson is performing hand-in-hand with the overall market and we can expect that McKesson will ...

In October of 2005, a Drug Enforcement Administration agent contacted drug distributor McKesson and said the federal agency ...

A former DEA opioid investigator testified as Baltimore’s first expert witness in its civil trial against a pair of drug ...

Robert W. Baird analyst Eric Coldwell downgraded the rating on McKesson (MCK – Research Report) to a Hold today, setting a price target of $531.00. Eric Coldwell’s rating is based on a series ...

McKesson was founded in 1833 ... government's centralized distributor of COVID-19 vaccines during the pandemic. In order to improve the value for its customers and shareholders, it uses methods ...

Deutsche Bank analyst George Hill maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $579.00. George Hill has given his Buy rating due to a combination ...

McKesson denied the allegations in a $37 million ... it wasn’t clear whether any of the planned executions would happen. A judge’s order forbidding the use of an execution drug came on an ...

There’s no reasonable explanation that I can imagine that would explain this amount in a city the size of Baltimore,” a ...

Shares of McKesson (MCK) fell sharply on Thursday. The healthcare services company issued a Q2 earnings forecast that underwhelmed investors. Meanwhile, Zimmer Biomet (ZBH) shares sank after the ...